Vanderbilt-Ingram Cancer Center’s Breast Specialized Program of Research Excellence (SPORE) has been awarded a third round of funding from the National Cancer Institute (NCI).

David Cortez, Ph.D., and his Vanderbilt colleagues report new findings that shed light on fundamental processes involved in DNA replication and have implications for cancer therapies that target these processes.

Vanderbilt researchers have identified a key regulator of cell division.

Magnesium and vitamin D appear to work together to reduce risk of death from cardiovascular disease and colorectal cancer.

Understanding the regulation of mutant EGF receptors commonly found in lung cancers could lead to new targeted therapies.

Molecular characterization of pre-cancerous changes in cells lining the stomach could point to lesions with a greater risk of progression to cancer.

Vanderbilt investigators used an in vivo screen in zebrafish to identify a potential new anti-cancer drug.